Fortress Biotech, Inc. (FBIO)
1.875
-0.12
(-5.78%)
USD |
NASDAQ |
Nov 13, 16:00
1.875
0.00 (0.00%)
After-Hours: 19:59
Fortress Biotech Price : 1.875 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2.00 | 2.065 | 1.92 | 1.99 | 297958.0 |
| Nov 11, 2026 | 1.94 | 2.035 | 1.93 | 2.01 | 382209.0 |
| Nov 10, 2026 | 2.00 | 2.00 | 1.895 | 1.91 | 179228.0 |
| Nov 09, 2026 | 1.90 | 2.00 | 1.85 | 1.99 | 289755.0 |
| Nov 06, 2026 | 1.82 | 1.87 | 1.82 | 1.85 | 129816.0 |
| Nov 05, 2026 | 1.98 | 1.98 | 1.79 | 1.84 | 307429.0 |
| Nov 04, 2026 | 1.98 | 2.06 | 1.94 | 1.97 | 124384.0 |
| Nov 03, 2026 | 1.91 | 1.98 | 1.884 | 1.94 | 100709.0 |
| Nov 02, 2026 | 1.89 | 1.94 | 1.86 | 1.93 | 198154.0 |
| Oct 30, 2026 | 2.01 | 2.01 | 1.89 | 1.92 | 196839.0 |
| Oct 29, 2026 | 2.00 | 2.069 | 1.970 | 2.00 | 179428.0 |
| Oct 28, 2026 | 1.94 | 1.98 | 1.905 | 1.96 | 125199.0 |
| Oct 27, 2026 | 1.90 | 1.95 | 1.87 | 1.93 | 157135.0 |
| Oct 26, 2026 | 1.91 | 1.92 | 1.85 | 1.87 | 116324.0 |
| Oct 23, 2026 | 1.98 | 1.989 | 1.91 | 1.93 | 223618.0 |
| Oct 22, 2026 | 1.94 | 2.01 | 1.93 | 1.99 | 183348.0 |
| Oct 21, 2026 | 1.935 | 1.96 | 1.915 | 1.94 | 178230.0 |
| Oct 20, 2026 | 1.88 | 1.95 | 1.875 | 1.94 | 293949.0 |
| Oct 19, 2026 | 1.88 | 1.89 | 1.83 | 1.87 | 251530.0 |
| Oct 16, 2026 | 1.92 | 1.925 | 1.84 | 1.87 | 264429.0 |
| Oct 15, 2026 | 1.91 | 1.95 | 1.88 | 1.91 | 219467.0 |
| Oct 14, 2026 | 1.93 | 1.945 | 1.88 | 1.90 | 376226.0 |
| Oct 13, 2026 | 2.09 | 2.106 | 1.93 | 1.95 | 443469.0 |
| Oct 12, 2026 | 2.12 | 2.134 | 2.10 | 2.11 | 114121.0 |
| Oct 09, 2026 | 2.12 | 2.17 | 2.09 | 2.135 | 186208.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 47.76 |
| Nektar Therapeutics | 37.27 |
| DiaMedica Therapeutics, Inc. | 8.79 |
| Journey Medical Corp. | 4.28 |
| ACADIA Pharmaceuticals, Inc. | 18.74 |
Price Related Metrics
| PE Ratio | 0.7058 |
| PS Ratio | 0.9220 |
| Price to Book Value | 0.3806 |
| Price to Free Cash Flow | 0.5248 |
| Earnings Yield | 141.7% |
| Market Cap | 62.46M |
| Normalized PE Ratio | 0.7657 |